Hepatology · 1994 · 72 citations · 18 references
PharmacyInfectious DiseasesPharmacotherapyHepatologyMolecular VirologyVirologyAntiviral TherapyInterferon ResponsesInterferon-based TherapyLiver DiseaseViral HepatitisViral Hepatitis TreatmentChronic Viral HepatitisHepatitis D Virus InfectionInterferon Alpha-2b TherapyNested Reverse Transcription Polymerase Chain Reaction
We examined the efficacy of decreasing high doses (beginning at 18 MU/day) of interferon-alpha 2a vs. that of daily low doses (3 MU) in the treatment of chronic hepatitis delta virus infection. Patients treated with 18 MU had a somewhat higher frequency of normalization of serum ALT levels than patients treated with low doses (31% and 12%, respectively, on an intention-to-treat basis). A decrease in the percentage of hepatitis D virus RNA positivity was observed in both groups at the end of treatment. Thus, whereas in baseline samples 10 (62%) of the patients in each group were positive for hepatitis D virus RNA in serum on slot-blot hybridization, these numbers decreased to 5 (31%) and 4 (25%) patients in groups 1 and 2, respectively, at the end of therapy. However, hepatitis D virus RNA, detected by means of nested polymerase chain reaction, remained in all but two (one in each group) patients who completed the treatment. Finally, during posttreatment follow-up, hepatitis D virus RNA levels returned to baseline values, and only one patient remained negative for this marker. The beneficial effect of interferon-alpha was only transient. Only two patients (one from each treatment group) had persistently normal serum ALT levels after 18 mo of follow-up. Finally, the presence of serum hepatitis D virus RNA at the end of therapy, detected with nested polymerase chain reaction, might be a good marker for the prediction of viral replication relapse.
18
Structure, sequence and expression of the hepatitis delta (δ) viral genome
Kang-Sheng Wang, Qui‐Lim Choo, Amy J. Weiner et al. · Nature · 1986 · 691 citations · Full text
INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B
Antonina Smedile, G Verme, Antonietta Cargnel et al. · The Lancet · 1982 · 533 citations
Viral Hepatitis and Liver Disease
Betty H. Robertson · Diagnostic Microbiology and Infectious Disease · 1988 · 417 citations
Medicine, Cardiology, Surgery +16
LeslieL. Iversen · The Lancet · 1982 · 392 citations
Mario Rizzetto, G Verme, S. Recchia et al. · PubMed · 1983 · 380 citations
Medicine, Pathology, Pharmacotherapy +16